About the Authors
- Lorenzo Romero-Ramírez
-
* E-mail: Hlromero@cajal.csic.es.
Affiliations Unidad de Neurología Experimental, Hospital Nacional de Parapléjicos, Toledo, Spain, Instituto Cajal de Neurobiología, CSIC, Madrid, Spain
- Isabel García-Álvarez
-
Affiliations Unidad de Neurología Experimental, Hospital Nacional de Parapléjicos, Toledo, Spain, Instituto de Química Orgánica General, Madrid, Spain
- Ramón Campos-Olivas
-
Affiliation Spectroscopy and NMR Unit. Structural Biology and Biocomputing Programme, Spanish National Cancer Center (CNIO), Madrid, Spain
- Michel Gilbert
-
Affiliation Human Health Therapeutics, National Research Council Canada, Ottawa, Ontario Canada
- Marie-France Goneau
-
Affiliation Human Health Therapeutics, National Research Council Canada, Ottawa, Ontario Canada
- Alfonso Fernández-Mayoralas
-
Affiliation Instituto de Química Orgánica General, Madrid, Spain
- Manuel Nieto-Sampedro
-
Affiliations Unidad de Neurología Experimental, Hospital Nacional de Parapléjicos, Toledo, Spain, Instituto Cajal de Neurobiología, CSIC, Madrid, Spain
Competing Interests
The authors have read the journal’s policy and have the following conflicts. The enzyme SOAT is protected by patent rights (WO 2007016792, MG co-inventor). The method and the use of O-acetylated gangliosides are protected by patent rights, (provisional application filed, PCT/ES2011/070732, LRR and MNS co-inventors). This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials. Dr. Ramon Campos-Olivas, coauthor of this manuscript, is currently member of the PLOS ONE editorial board. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: LRR IGA RCO AFM MNS. Performed the experiments: LRR IGA RCO. Analyzed the data: LRR IGA RCO AFM. Contributed reagents/materials/analysis tools: LRR IGA RCO MG MFG AFM MNS. Wrote the paper: LRR IGA RCO MFG AFM MNS.